S227928

· Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S227928, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML [Phase 1, Phase 2]

See pricing